2024. Plasma miR-19b, miR-34a, and miR-146a expression in patients with type 2 diabetes mellitus and cataract: A pilot study. Biomolecules and Biomedicine. (May 2024), 537–544. DOI:https://doi.org/10.17305/bb.2023.9933.